Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and MODS

rosiglitazone has been researched along with MODS in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, L; Liu, ML; Miao, F; Pei, HH; Qiao, WH1
Harn, HJ; Hsu, BG; Lee, CJ; Lee, RP; Peng, TC; Subeq, YM; Yang, FL1
Caputi, AP; Chatterjee, PK; Cuzzocrea, E; Cuzzocrea, S; Di Paola, R; Di Rosa, M; Dugo, L; Fulia, F; Genovese, T; Ianaro, A; Patel, NS; Pisano, B; Thiemermann, C1
Fink, MP1

Other Studies

4 other study(ies) available for rosiglitazone and MODS

ArticleYear
[Effects of peroxisome proliferators-activated receptor-gamma on the function of the vital organs in rats with pancreatitis].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2008, Volume: 28, Issue:6

    Topics: Anilides; Animals; Hypoglycemic Agents; Injections, Intravenous; Male; Multiple Organ Failure; NF-kappa B; Pancreatitis, Acute Necrotizing; PPAR gamma; Random Allocation; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones

2008
Rosiglitazone protects against severe hemorrhagic shock-induced organ damage in rats.
    Medical science monitor : international medical journal of experimental and clinical research, 2011, Volume: 17, Issue:10

    Topics: Animals; Anti-Inflammatory Agents; Blood Chemical Analysis; Blood Pressure; Chemokine CCL2; Enzyme-Linked Immunosorbent Assay; Heart Rate; Interleukin-6; Multiple Organ Failure; Rats; Rats, Wistar; Rosiglitazone; Shock, Hemorrhagic; Survival Analysis; Thiazolidinediones; Tumor Necrosis Factor-alpha

2011
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
    Critical care medicine, 2004, Volume: 32, Issue:2

    Topics: Animals; Lipid Peroxidation; Male; Mice; Multiple Organ Failure; Nitric Oxide; Nitrosation; Rosiglitazone; Shock; Thiazolidinediones; Zymosan

2004
Peroxisome proliferator-activated receptor-gamma ligands: a pluripotent class of pharmacological agents that may prove to be useful for adjuvant treatment of sepsis and multiple organ dysfunction syndrome.
    Critical care medicine, 2004, Volume: 32, Issue:2

    Topics: Animals; Clofibrate; Humans; Lipid Peroxidation; Multiple Organ Failure; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Sepsis; Thiazolidinediones; Transcription Factors

2004